Silverback Therapeutics
Price & Volume
Stats
See more52W Range | $7.55-$18.51 |
Market Cap | $1.4B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $89.1M |
Revenue Growth (YoY) | 4,900% |
Gross Profit (12 Mos) | $68.5M |
Diluted EPS | $0.07 |
News
See moreYahoo Finance • 17 days ago
ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms
Yahoo Finance • 19 days ago
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences
Yahoo Finance • 30 days ago
ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy® (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients
Yahoo Finance • last year
ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates
About
Address | 11682 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 155 |
